ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2025
Efficacy and safety of endovascular treatment for iatrogenic renal injuries following percutaneous interventions.
Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy and safety of empiric transcatheter arterial embolization for acute arterial upper gastrointestinal bleeding: A tertiary-care, single-center experience.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRenal artery embolization (RAE) is a minimally-invasive therapeutic option for iatrogenic renal vascular injuries (IRVIs).
aimWe aimed to assess the efficacy and safety of RAE in treating IRVIs resulting from percutaneous interventions. MATERIALS AND
methodsThe study included 34 patients (25 men, 9 women; mean [SD] age, 49.1 [18.9] years) who were treated with RAE for IRVIs at our center between February 2019 and May 2025. The etiology and type of IRVIs, hemoglobin levels, accompanying radiological findings, and parameters related to the RAE procedure were retrospectively analyzed.
resultsAmong the 34 patients, the etiology of IRVI was percutaneous biopsy in 17 individuals and percutaneous nephrolithotomy in the remaining 17 cases. A total of 35 RAE procedures were performed (1 reintervention). The IRVIs were classified as active extravasation (n = 24), pseudoaneurysm (n = 9), and arteriovenous fistula (n = 2). Parenchymal laceration was observed in 10 patients, and a collecting system injury was noted in 1 individual. The embolic agents used were coils (49%), N-butyl cyanoacrylate mixed with lipiodol (28%), polyvinyl alcohol (PVA) particles (14%), a combination of coils, glue, and lipiodol (6%), and a combination of PVA particles and coils (3%). The technical success rate was 100%, while the clinical success rate was 97%. Only 1 patient required reintervention due to persistent hemorrhage. Minor complications occurred in 3 patients, and no major complications were observed.
conclusionsRAE is a safe, highly effective, and minimally-invasive treatment for IRVIs. The procedure offers additional advantages, including nephron preservation and the potential for repeat intervention, if necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.